Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07217899 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prophylactic Intravenous Calcium Gluconate to Decrease Blood Loss at Time of Cesarean Delivery in Pregnant Patients at High Risk for Uterine Atony

StatusRecruiting
PhasePhase 2
Started2025-10-20
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 months later Jul 2026 → Oct 2026
See other at-risk trials from University of Michigan

Amendment history

2026-07-22
Study Status v2
Primary completion pushed: 2026-07 → 2026-10
Completion pushed: 2026-08 → 2026-12
2025-10-28
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2025-10-15→confirmed 2025-10-20
Study sitesdetails revised at 1 of 1 site
2025-10-14
Original filing
This research study is being done to learn what effect a single dose of calcium gluconate will have on blood loss at the time of cesarean delivery in pregnancy patients at high risk for uterine atony.
Trial Details
NCT Number NCT07217899
Lead Sponsor University of Michigan
Conditions Blood Loss, Surgical, Blood Loss, Postoperative, Uterine Atony
Enrollment 140 participants
Start Date 2025-10-20
Primary Completion 2026-10 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-24